美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=APREPITANT"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
APREPITANT 211835 001 ANDA APREPITANT CAPSULE;ORAL 40MG No No 2020/10/21 2020/10/21 TORRENT Prescription
APREPITANT 211835 002 ANDA APREPITANT CAPSULE;ORAL 80MG No No 2020/10/21 2020/10/21 TORRENT Prescription
APREPITANT 211835 003 ANDA APREPITANT CAPSULE;ORAL 125MG No No 2020/10/21 2020/10/21 TORRENT Prescription
FOSAPREPITANT DIMEGLUMINE 203939 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2020/12/08 2020/12/08 SANDOZ Discontinued
FOSAPREPITANT DIMEGLUMINE 211160 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2020/12/09 2020/12/09 DR REDDYS Prescription
FOSAPREPITANT DIMEGLUMINE 210625 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2021/01/12 2021/01/12 EUGIA PHARMA Prescription
FOSAPREPITANT DIMEGLUMINE 212143 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2021/03/03 2021/03/03 CHIA TAI TIANQING Prescription
FOSAPREPITANT DIMEGLUMINE 214616 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2021/07/29 2021/07/29 ASPIRO Prescription
FOSAPREPITANT DIMEGLUMINE 213199 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2021/10/04 2021/10/04 ARTHUR GRP Discontinued
FOSAPREPITANT DIMEGLUMINE 214683 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2023/05/16 2023/05/16 PIRAMAL CRITICAL Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database